Our News on Newswise

Newswise: 631a0405a6817_ACTRIMSForum2023-Logo-PrimaryStacked.jpg

ACTRIMS Forum 2023 themed MS: Going Viral

The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual Forum will be held Feb. 23-25, 2023, in San Diego, California at the Marriott Marquis San Diego Marina. Themed “MS: Going Viral,” the Forum 2023, will...
8-Sep-2022 1:05 PM EDT Add to Favorites

Newswise: 620eb70cabfe4_Bar-Or-A,-formal-pic-headshot-jpg-(1).jpeg

ACTRIMS Board Member Dr. Amit Bar-Or Wins Barancik Prize for Innovation in MS Research

The National MS Society announced that Amit Bar-Or, MD, the Melissa and Paul Anderson President’s Distinguished Professor of Neurology at the Perelman School of Medicine at the University of Pennsylvania is this year’s recipient of the Barancik...
17-Feb-2022 4:05 PM EST Add to Favorites

Evolution of the Neuroinflammatory Response Over the Clinical Course of MS

Benjamin M. Segal, M.D., The Ohio State University, to present keynote address at ACTRIMS Forum 2021
22-Feb-2021 1:05 PM EST Add to Favorites

The Spectrum of Multiple Sclerosis will be the focus at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2021 Forum

Forum Announcement
19-Jan-2021 11:40 AM EST Add to Favorites

Q&A with Leaders of MS Virtual 2020 Conference

ACTRIMS MS Virtual 2020 Q&A with Association Leadership
16-Sep-2020 5:10 PM EDT Add to Favorites

Brain microstructural and metabolic alterations detected in vivo at the onset of the first demyelinating event


22-Sep-2020 10:30 AM EDT Add to Favorites

Network analysis identifies gut bacteria associated with multiple sclerosis relapse among pediatric-onset patients


22-Sep-2020 11:05 AM EDT Add to Favorites

Phase 2 clinical trial evidence that a retinoid-X receptor agonist promotes remyelination in people with relapsing-remitting multiple sclerosis


22-Sep-2020 10:05 AM EDT Add to Favorites


See All News

Our YouTube Videos

About

Founded in 1995, Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS®) is a community of leaders from the United States and Canada who are dedicated to the treatment and research in MS and other demyelinating diseases. ACTRIMS focuses on knowledge dissemination, education and collaboration among disciplines. ACTRIMS also provides an annual Forum for experienced and newer clinicians and researchers to exchange information, debate current issues and discuss advances related to basic research and clinical issues. One of the major initiatives of ACTRIMS is to foster the careers of young neurologists in training who have an interest in multiple sclerosis; this is done through a Resident Summit held in conjunction with the annual Forum and a standalone summit geared towards young scientists.

Experts

Contacts

Jennifer Brydges
Managing Director

jbrydges@actrims.org

608-310-8960

Diana Peterson
Operations Manager

dpeterson@actrims.org

Amanda Safa
Senior Meetings Manager

asafa@actrims.org

Karisa Trudgeon
Marketing and Communications

ktrudgeon@actrims.org

608.310.8960

Twitter

close
0.84097